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Abstract
A new treatment tested in laboratory animals increases synaptic membrane and
cholinergic neurotransmission. This treatment involves giving three compounds; DHA, a
phosphatide precursor; choline, another phosphatide precursor present in the rodents'
diets but not varied in this study; and UMP, a precursor of CTP, the rate-limiting
compound in Kennedy Cycle production of phosphatides. Their administration increases
the quantities of phosphatides, the major constituent of neuronal membrane, per brain
cell, as well as specific synaptic proteins, the number of dendritic spines; and the
expression of genes related to hippocampal glutamatergic neurotransmission. Since such
membrane is the predominant component of synapses, the treatment might also
ameliorate the loss of synapses occurring in the brains of Alzheimer's patients. My study
involves assessing the behavioral effects of the treatment in individual rats or gerbils
subsequently shown to manifest its neurochemical effects (i.e., increased phosphatides).
My present findings show that the treatment improves performance on various tests of
memory function. The largest improvements in memory function and increases in
phosphatide levels are observed when DHA, choline, and UMP are consumed in
combination.
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Introduction
Our laboratory has been interested in the ability of several circulating compounds,
uridine monophosphate [UMP], docosahexaenoic acid [DHA], and choline - to increase
the production of membrane phospholipids in brain and, concurrently, to increase brain
levels of pre- and post- synaptic proteins (1) and the density of dendritic spines in the
hippocampus (2). Hence I undertook a series of experiments to determine whether this
treatment could also enhance various cognitive functions in experimental animals. My
initial studies utilized gerbils, because pyrimidine metabolism in this species (but not in
rat) is similar to that in humans (1).
Briefly, gerbils consumed UMP through their diet, and received DHA by daily
gavage, and effects on learning and memory were assessed via the four arm radial maze,
T-maze, and Y-maze tasks. I found that gerbils consuming UMP outperformed their
control counterparts in every task. Likewise, gerbils administered DHA outperformed
both the control, and the UMP-fed groups. Finally, gerbils receiving both UMP and
DHA outperformed all other groups tested (Chapter 1). In subsequent studies on rats
receiving dietary UMP and gavaged DHA, I compared the effects of these phosphatide
precursors on animals that had been exposed to enriched or impoverished environments;
learning and memory were assessed using the hidden and visible versions of the Morris
water maze. I found that giving UMP plus DHA protected environmentally-impoverished
rats from the cognitive decline usually associated with impoverishment; in contrast, the
UMP plus DHA did not enhance memory among environmentally-enriched rats (Chapter
2).
Measurements of whole brain phospholipid levels in gerbils and rats revealed that
the increases in these levels caused by UMP and DHA correlated with their
improvements in memory functions (Chapter 1, 2). Interestingly, rats exposed to an
enriched environment had significantly higher whole brain phospholipid levels than those
exposed to an impoverished environment; likewise otherwise-untreated environmentally-
enriched rats outperformed impoverished rats on the hidden version of the Morris water
maze (Chapter 2).
I elected to test learning and memory in gerbils using the radial maze, T-maze,
and Y-maze because these methods allow for simultaneous recordings of both working
and reference memory. Preliminary experiments also indicated that UMP and DHA can
not be shown to affect cognitive function using high thoroughput assays, so I used
protocols that allowed for one trial a day thus increasing the intertrial delay. The Morris
water maze, a more standard test of memory, was not used to study gerbils because this
species had difficulty learning how to swim, and thus the test itself would have been a
stressor.
I chose to test the cognitive affects of UMP and DHA in impoverished and
enriched rats using both the hidden and the visible versions of the Morris water maze
because these tasks test two different types of memory. The hidden version measures
hippocampal-dependent memory, and relies on spatial cues; the visible version measure
striatal-dependent memory, and relies on habitual learning. Altering the rats'
environmental conditions was incorporated in my studies because doing so provided a
way to induce cognitive impairment (impoverished conditions) or cognitive enhancement
(enhanced conditions), and UMP had previously been found in our laboratory to enhance
cognition in impoverished rats (3). We hypothesized that UMP plus DHA would
improve the memory functions of rats, including both impoverished and enriched rats,
since giving UMP plus DHA increases phospholipid levels and enhances cognition in
normal adult gerbils (Chapter 1).
1. Wurtman RJ, Ulus IH, Cansev M, Watkins CJ, Wang L, Marzloff G. Synaptic
proteins and phospholipids are increased in gerbil brain by administering uridine
plus docosahexaenoic acid orally. Brain Res, 2006; 1088: 83-92.
2. Sakamoto T, Cansev M, Wurtman RJ. Oral supplementation with
docosahexaenoic acid and uridine-5'-monophosphate increases dendritic spine
density in adult gerbil hippocampus. Brain Res, 2007; 1182: 50-9.
3. Teather LA, Wurtman RJ. Chronic administration of UMP ameliorates the
impairment of hippocampal-dependent memory in impoverished rats. J Nutr,
2006; 136: 2834-7.
Chapter 1:
Dietary Uridine Enhances the Improvement in Learning and Memory
Produced by Administering DHA plus Choline to Gerbils
Sarah Holguin, Joseph Martinez, Camille Chow, Richard Wurtman
Abstract
Docosahexaenoic acid (DHA) and choline, two circulating precursors for brain
phosphatides, can each improve cognitive abilities when administered to humans
and experimental animals: DHA consumption enhances learning and memory in
premature infants, and also in aged rats or rats infused intracerebrally with
amyloid beta. Choline administration early in life improves learning and memory
in adult gerbils, and choline also does so in malnourished humans. In the present
study, we show that oral DHA, co-administered to gerbils with choline chloride,
improves performance on various tests of learning and memory, including the
four arm radial maze (p < 0.001); T-maze (p< 0.021); and Y-maze (p < 0.001); as
described previously this treatment concurrently increases brain phosphatide
levels (p < 0.001). Co-administering a uridine source [uridine monophosphate
(UMP)] with DHA plus choline further enhances the increases in cognitive scores
and phosphatide levels. The uridine probably acts by generating CTP, which can
be limiting in phosphatide synthesis, and UTP, which activates P2Y receptors.
Introduction
Consumption of certain nutrients can influence brain function, even when the
nutrients are not being used to correct malnutrition syndromes (1). Consumption of
omega 3 fatty acids can improve cognition in animals or humans (2) or when given to
developing (3), or aged rats (4), or to rats infused intracerebrally with amyloid beta (5).
Aged rats consuming DHA for three weeks exhibited improved performance when tested
on an 8-arm radial maze (4); dentate gyri basally contained reduced DHA levels, which
were returned to normal after they consumed DHA-enriched diet for eight weeks (6).
The DHA may have acted by increasing brain phosphatide levels, thus enhancing
synaptic transmission (7; 8) and thereby improving cognition (9). Pups of dams fed a
DHA-enriched diet exhibited accelerated neurologic development (10), similarly treated
animals performed better on the Morris water maze as adults (11). DHA administered
chronically to rats reversed the behavioral impairment caused by infusing beta-amyloid
into the right ventricle (12), and rats fed a DHA-deficient diet had longer escape latencies
than control animals when tested on the Morris water maze (11).
Raising circulating and brain DHA levels can enhance the levels ofphosphatides and
of specific proteins in synaptic membrane (7), and the density of hippocampal dendritic
spines (13); this increase in dendritic spines could enhance synaptic transmission in the
hippocampus. Oral administration of UMP, a source of circulating and brain uridine
(14), also promotes the synthesis of synaptic phosphatides and proteins (7), acting via its
phosphorylated products UTP (which stimulates P2Y receptors [15]) and CTP
(which is rate-limiting in phosphatide synthesis via the Kennedy cycle [16]). Moreover,
the effects on phosphatide synthesis of giving UMP to animals receiving DHA and
choline tends to be substantially greater than the sum of the increases after either
treatment alone (7).
Numerous investigations have described improvements in learning and memory
among animals given a uridine source: local application of UMP into the hippocampus
thirty minutes prior to acquisition of the Y-maze reportedly improved performance as
examined forty-eight-hours later (17). Also, consuming a diet enriched with UMP
reversed the memory impairment usually observed among rats reared under impoverished
environmental conditions (18). Consumption of UMP along with DHA plus choline
amplified the increases in hippocampal dendritic density produced by givingUMP or
DHA plus choline alone (7, 13).
The ability of DHA, uridine, and choline to increase brain phosphatide synthesis
derives from the kinetic properties of the enzymes involved: all are of low affinity, and
thus unsaturated with their substrates. Choline is phosphorylated by choline kinase (CK)
to form phosphocholine, uridine is phosphorylated by uridine-cytidine kinase (CDK) to
form uridine triphosphate (UTP) (19), which is transformed to cytidine triphosphate
(CTP) by the enzyme CTP synthetase (20); DHA is taken up into and acylated by fatty
acyl-CoA synthetase, in neurons (21). Phosphocholine and CTP combine to form
cytidine- 5-diphosphocholine (CDP-choline), which combines with diacylglycerol
(DAG), preferentially that containing polyunsaturated fatty acids (PUFA) like DHA (21,
22) to form phosphatidylcholine (PC) (16). At normal plasma and brain levels (20), the
synthesis of PC by choline kinase (CK) is enhanced in animals (23) or humans (24) given
choline because CK is not saturated by choline (20). The conversion of uridine to UTP
and CTP is enhanced in PC12 cells (15) and rodent brain (7) when the saturation of
uridine-cytidine kinase (UCK) (25, 26, 27, 28, 29, 30), has been increased by providing
the pyrimidine (19). Plasma and brain CTP concentrations do not saturate CTP:
phosphocholine cytidylyltransferase (CT) (31), or the uptake into brain (32). Giving
animals DHA and choline plus uridine increases enzyme saturation by all three of these
precursors, and thus maximally enhances the synthesis of PC and other phosphatides (7).
We examined the effects on cognitive functions of giving gerbils UMP, DHA or both,
plus a choline-supplemented diet, and correlated those effects with the increases in their
produced brain membrane phosphatides. In humans, uridine is the principal circulating
pyrimidine; however, in rats, the principal circulating pyrimidine is cytidine, not uridine
(33). Pyrimidine metabolism in gerbils more closely resembles that in humans, hence, we
used Mongolian gerbils and not rats in this study. The gerbils received UMP and choline
via the diet and DHA by gavage, for four weeks prior to cognitive testing on a four arm
radial maze, T-maze or Y-maze.
Materials and Methods
Animals
Male gerbils (Meriones unguiculatus) (60-80 g) purchased from Charles River
Laboratories, Wilmington, MA, were housed in pairs, in a climate-controlled area kept on
a 12:12 light cycle (lights on at 7:00 h). An enriched environment was provided by
placing toys in the cage, providing a fresh paper towel for shredding twice a week, and
housing the animals in pairs. Each experiment was repeated at least 3 times and by at
least 2 different experimenters who were blind to the treatments. Efforts were made to
minimize animal suffering, according to NIH guidelines. Protocols were approved by the
Massachusetts Institute of Technology Committee on Animal Care (MIT's Institutional
Animal Care and Use Committee [IACUC]).
Treatments
Gerbils were allowed to eat 16% protein chow, or the same diet supplemented
with 0.5% UMP (Harlan-Teklad, Madison, WI). All diets contained 0.1% choline
chloride. Gerbils weighing 80g. typically consumed 4g. of food per day. In addition,
gerbils were gavaged daily with either a vehicle solution containing 5% arabic gum in
saline or the same vehicle supplemented with 300mg/kg DHA. At 3 months of age,
gerbils consumed UMP by dietary supplementation and DHA by gavage for four weeks
prior to behavioral training, and throughout all phases of behavioral testing.
4-Arm radial maze apparatus
The 4-arm radial maze apparatus consisted of a plastic square platform (15 cm x
15 cm), with 4 enclosed metal arms (10 cm x 37.5 cm), each with a small semi-
cylindrical trough (7.5 cm diameter x 2 cm deep) located 2.5 cm from the distal end 105.
for placing a food reward (.5 cm x .5 cm food pellet). The platform and arms were 106.
opaque (white) and 25 cm tall, without a top. The maze was located in a testing room
devoid of sound but with ample spatial cues including counters, chairs, etc. A 108.
constant level of ceiling illumination was provided throughout the study.
Radial maze training and behavioral measures
Food and water were available ad libitum until the day of experimental testing, at
which point gerbils were first fasted for 17 hours overnight and then provided with food
from 11AM to 6PM. Gerbils were handled daily for 4 days before testing to habituate
them to routine contact. They were familiarized with the maze for an additional 4 days by
placing food pellets throughout the arms and allowing 3 min for exploration. Gerbils
received 1 trial/day, and all surfaces were sanitized with 10% ethanol followed by
quatricide between trials. Arms were also rotated between each trial to ensure that
gerbils did not follow each others' scent to locate the food pellet. Training consisted of
placing a food pellet at the distal end of the same 2 arms for all trials. The gerbil was
placed in the center of the maze and allowed 2 min to find the food pellets. Testing
continued at the same time each day until gerbils had learned the task sufficiently well
(>80% accuracy for 3 consecutive days).
Working memory errors were recorded whenever a gerbil re-entered an arm
which contained a food pellet and which had previously been visited during a trial.
Reference memory errors were recorded whenever a gerbil entered an arm that had
not contained a food pellet during previous trials. The time it took to find both food
pellets and the path length chosen to obtain the pellets were also recorded.
T-maze apparatus
The T- maze apparatus consisted of a square platform (15 cm x 15 cm), with three
arms (10 cm x 37.5 cm) in the shape of a "T", each with a small cylindrical trough 131.
(7.5 130. cm diameter x 2 cm deep) located 2.5 cm from the distal end for placing a 132.
food reward (.5 cm x .5 cm food pellet). The platform and arms are opaque (white) 133.
and 25 cm tall. The maze was located in a testing room devoid of sound but with 134.
ample spatial cues including counters, chairs, etc. A constant level of ceiling illumination
was provided throughout the study.
T-maze training and behavioral measures
Food and water was available ad libitum until the day of testing. Gerbils
consumed 0.5% UMP-supplemented diet or control diet were given 300mg/kg of 139.
DHA (or its vehicle) daily by gavage at approximately three months of age, four 140.
weeks prior to behavioral training. Gerbils were handled daily for four days the week
prior to testing to habituate them to routine contact and were familiarized with 142. the
maze for an additional four days by placing food pellets throughout the arms and 143.
allowing three minutes for exploration. They were fasted for seventeen hours overnight,
tested on the T-maze, and then provided with food from 11 a.m. to 6 p.m. 145. They
continued to receive UMP and/or DHA throughout the remainder of training, 146.
approximately nine weeks total. They received one trial/day for five weeks. Training
consisted of placing a food pellet at the distal end of one arm in the "hat" 148. of the T.
The gerbils were placed at the end of the base of the T and allowed two 149. minutes to
find the food pellet. All surfaces were sanitized with quatricide and 10% 150. ethanol
between trials. Arms were also rotated between each trial to ensure that gerbils did not
follow each others' scent to locate the food pellet.
Working memory errors were recorded whenever a gerbil re-entered an arm that
contained a food pellet and after consuming the food pellet. Reference memory errors
were recorded whenever a gerbil entered an arm that did not contain a food pellet during
previous trials. The time required to find the food pellets and the path length used to
obtain the pellets were also recorded.
Y-maze apparatus
The Y-maze apparatus consisted of a wooden square platform (25 cm x 25 cm),
with one removable wall opening into the corner of a 120 0 triangular region (side
length 60 cm). All walls were 25 cm tall without a top. Two hinged doors (10 cm x
15 cm), were located symmetrically (10 cm from edge) on the wall opposite the square
platform. Behind one door was the gerbil's home cage, and behind the other door was an
identical clean cage. The maze was located in a testing room devoid of sound but with
ample spatial cues including counters, lamps, etc. A consistent level of ceiling
illumination was provided throughout the study.
Y-maze training and behavioral measures
Animals were first handled daily for 4 days to habituate them to routine contact.
Food and water were available ad libitum. Gerbils began to eat UMP-supplemented 169.
chow at 3 months of age, 2 weeks prior to behavioral training, and continued to do 170.
so throughout the remainder of training. Animals were not fasted for this test. Gerbils
underwent 3 trials per day, and all surfaces were sanitized with 10% ethanol 172.
between trials. Cages were also rotated between each trial to ensure that gerbils did 173.
not follow each others' scent to locate the food pellet. Training took place for 4
consecutive days, followed by 4 days of no training, and 4 days of training .
Training consisted of placing a gerbil in the square platform for 5 sec, removing the
removable wall, and allowing the gerbil 3 min to choose which door to enter.
Animals were not able to re-enter the testing chamber after entering a door. Trials 178.
followed the same procedure. The door chosen during each trial was recorded.
Rotarod apparatus and testing
The rotarod apparatus consisted of a 3.2-cm-diameter rod (RRAC-3002; O'Hara
& Company, Tokyo, Japan). The rotarod test was performed according to the
procedure described previously (34). Male gerbils, 5 months old, were used for
motor behavioral tests. During the training period, gerbils were placed on the
rotating rod starting at 4 rpm and gradually accelerated to 40 rpm at a rate of 0.15
rpm/s. The latency to fall (retention time) was measured with a cutoff time of 4 min.
Gerbils were trained for 3 consecutive days, receiving four trials per day with a 1 h
intertrial interval.
Sample Collection
Gerbil brains were obtained immediately following the conclusion of each
behavioral test by CO 2 anesthesia followed by decapitation and immediate dissection of
the whole brain. All brain tissue was weighed and homogenized in DI water such that
each sample contained the same ratio of tissue to water; i.e., 20mg tissue: lmL water.
Samples were stored at -80 C for further analysis.
Total DNA Assay
To determine the total DNA in each sample, previously described techniques (35)
were used. Briefly, known standards were diluted 50 ltg/mL in DNA buffer (50mM
KPO4, 2mM EDTA, 250mM NaC1, pH=7.4); 10 ýtL of standards and homogenized
tissue were placed in well plates (Falcon Micro Test 96-well Assay Plate, optilux Black).
Hoechst solution was diluted to 1 .tg/ýL in DNA buffer, and 200[tL was added to
standard- and sample-containing wells. Following a thirty minute incubation at RT and
in the dark, the plate was read and analyzed on Thermo Labsystem Fluoroskan Ascent
using Micro plate Manager Software at 450 nm.
Total Protein Assay
To determine the total protein in each sample, previously described techniques
(35) were used. Homogenized brain tissues were compared to known BSA standards.
Briefly, BSA standards and samples were added to well plates (clear Falcon Pro-Bind 96
well assay plate); CuSO4 solution was diluted 1:49 in bichinconinic acid and added to all
standard- and sample-containing wells. Following a thirty-minute incubation at RT, the
plate was read and analyzed on a 210. Bio Rad micro plate reader, model 550, using
Ascent Software at 450 nm.
Total Phospholipids Assay
Total phospholipid content was determined by comparing samples to potassium
phosphate standards. Phosphatides were extracted using previously described methods
(36): 1 mL homogenates were mixed with 3 mL of chloroform and methanol mixture (2:1
v/v) and vortexed for 30 seconds. After cooling on ice for 1 hour, the mixture was added
to 1 mL deionized water, and then added to 3 mL of chloroform and methanol (2:1 v/v).
After remaining at -4C for 18-20 hours, the mixture was separated by centrifugation at
3500 rpm for fifteen minutes at 4C; 100 ýtL aliquots of the bottom phase are dried in a
Savant lyopholizer and then digested in 70% perchloric acid for 1.5 hours at 150 C.
Phosphatides were measured as described previously (37): 300 ýIL of 15% ascorbic acid
and 200 tL of 5% ammonium molybdate were added to samples and standards. These
remained at RT for thirty minutes, and were then read at 450 nm on a Perkin-Elmer
Lambda 3B 224. UV/VIS.spectrophotometer. The absorbency reading of each sample
was compared 225. to the absorbency reading of the standards to determine the
phospholipid content in samples. This value was adjusted according to the total DNA
and protein determined previously.
Separation ofPhospholipids
To determine the amount of individual phospholipids, previously described
methods (38) were used. Digested samples were separated using thin layer
chromatography (TLC); 30 jtL of each sample was spotted onto Alltech silica gel G
channeled plates, placed in running buffer (30 mL chloroform, 34 mL ethanol, 30 mL
triethylamine, and 8 mL water) for 1.5 hours, and visualized by spraying plates with
petroleum ether containing 1,6-diphenyl- 1,3,5-hexatriene and viewing under UV light.
The bands corresponding to individual phospholipids were scraped, reconstituted in
methanol, and dried overnight in a Savant lyopholizer. Following this initial separation
step, samples were digested and assayed for phosporus as described for total
phospholipids above.
Data analysis
For all tests comparing 2 groups, two-tailed t-tests were used. For comparisons
involving more than one factor, or comparing more than 2 groups, factorial ANOVA 242.
was used.
Results
Body wt.
Body weight did not differ between UMP-supplemented, DHA gavaged, and
control groups (data not shown), indicating that gerbils probably were eating
equivalent amounts of diet with or without UMP or DHA supplementation.
Effects of UMP and DHA Supplementation on Gerbils Performance on a Four Arm
Radial Maze.
All groups were able to learn the four arm radial maze to some degree, showing a
decrease in the number of errors recorded over time (figure lA, B, C). Values are mean
± S.E.M, n=12. Reference memory errors were decreased by administration of either
UMP or DHA, the largest decrease was observed by co-administering UMP and DHA;
UMP [F(1,12)= 5.721, p<.038], DHA [F(1,12)= 12.315. p< .042, and UMP x DHA
[F(1,12) = 23.659, p< .001] (figure lA). Working memory errors were decreased by
administration of either UMP or DHA, the largest decrease was observed by co-
administering UMP and DHA; UMP [F(1,12) = 7.236, p< .029], DHA [F(1,12) = 19.145,
p < .035, UMP x DHA [F(1,12) = 17.329, p < .001] (figure IB). The total errors were
decreased by administration of either UMP or DHA, the largest decrease was observed by
co-administering UMP and DHA; UMP [F(1,12) = 8.237, p<.022], DHA [F(1,12)=
9.658, p< .034], UMP x DHA [F(1,12) = 18.521, p<.001) (figure IC). These results
indicate that long-term dietary treatment with UMP or oral DHA improves gerbils'
spatial memory; their spatial memory is further enhanced when UMP and DHA are co-
administered.
Effects of UMP and DHA Supplementation on Gerbils Performance on a T-Maze
with a Delayed Memory Test.
All groups were able to learn the T- maze to some degree, showing a decrease
in the number of errors recorded over time (figure 2A). Values are mean ± S.E.M, n=12.
The number of sessions required for gerbils to reach the criterion to have successfully
learned the maze were decreased by administration of either UMP or DHA, the largest
decrease was observed by co-administering UMP and DHA; UMP [F(1,12) = 5.764,
p<.038], DHA [F(1,12) = 7.861, p < .024, and UMP x DHA [F(1,12) = 16.325, p< .017]
(figure 2A). Following a 24 hour delay, gerbils administered with either UMP or DHA
were more likely to locate the correct arm; the gerbils most likely to locate the correct
one were those administered both UMP and DHA; UMP [F(1,12) = 7.365, p < .04], DHA
[F(1,12) = 6.295, p < .036, UMP x DHA [F(1,12) = 18.263, p< .021] (figure 2B). These
results indicate that long-term dietary treatment with UMP or oral DHA improves
gerbils' retention of spatial memory following a delay in testing; their retention of
spatial memory was further enhanced when UMP and DHA were co-administered.
Effects of UMP and DHA Supplementation on Gerbils Performance on a Y-Maze
with a Delayed Memory Test.
All groups were able to learn the Y- maze to some degree, showing an
increase in the number of times gerbils chose the correct door to their home cage
(figure 3), and indicated by a significant main effect of day (block of four training
trials/day) (P<.001). Values are mean ± S.E.M, n=12. No other significant main
effects were determined during acquisition of the task. Following a four day delay,
gerbils administered either UMP or DHA were more likely to choose the correct door, the
group most likely to choose the correct door were the gerbils co-administered UMP and
DHA; UMP [F(1,12) = 8.326, p<..012], DHA [F(1,12) = 10.296, p < .009, and UMP x
DHA [F(1,12) = 22.356, p< .001] (figure 3). These results indicate that long-term dietary
treatment with UMP or oral DHA improves gerbils' retention of spatial memory
following an extended delay in testing; their retention of spatial memory was further
enhanced when UMP and DHA were co-administered.
Effects of UMP and DHA Supplementation on Gerbils Performance on an
Accelerating Rotarod Test
All groups were able to learn the rotarod task, showing an increase in the length of
time they are able to remain on the accelerating rotarod (figure 4), and indicated by a
significant main effect of day (block of four training trials/day) (p<.02). Values are mean
+ S.E.M, n=12. No other significant main effects were determined (p's > .05),
suggesting that a UMP-supplemented diet and/or oral DHA has little to no effect on
motor activity.
Effects of a UMP- supplemented Diet alone or in Combination with DHA
Administration on Brain Phosphatide Levels
Chronic consumption of UMP (0.5%) increased gerbils' brain PC and PE levels
significantly, by 18%, and 33%, respectively (table 1). Administration of DHA (300
mg/kg) to gerbils consuming control diet increased gerbils' brain PC, PE, PS, and PI
levels significantly, by 26%, 10%, 50%, and 53%, respectively. Among gerbils receiving
both UMP and DHA, brain PC, PE, SM, PS, and PI levels rose significantly by 66%,
108%, 100%, 75%, and 94%, respectively. Total phospholipid levels were also
significantly increased in gerbils administered both UMP and DHA, by 32% (table 1).
Two-way ANOVA revealed a significant effect of dietary UMP or oral DHA on brain
PC, PE, PS, and PI levels (all < .05). Two way ANOVA also revealed a significant
effect of co-administering dietary UMP and oral DHA on brain PC, PE, SM, PS, PI, and
total phospholipids levels (all P < .001). Similar results were obtained when data were
expressed per ýtg DNA (data not shown).
Table 1. Effects of giving UMP-supplemented diet (0.5%) and
phosphatide levels in whole brain samples.
DHA (300 mg/kg) on
Treatment Total PL PC PE SM PS PI
Control 343+ 12 138 ± 11 58 ± 7 37 ± 8 24 ± 8 17+7
0.5% UMP 364 + 15 164 ± 12* 77 ± 10* 42 ± 5 32 ± 8 24 ± 7
300mg/kg DHA 411 ± 6 174 + 9* 64 9* 40 ± 9 36± 11* 26 9*
0.5% UMP + 300mg/kg 452 - 18*** 229 ± 121 + 74 ± 42 ± 33 +
DHA 15*** 13*** 10"** 12*** 4***
319. Gerbils were administered a UMP-containing (0.5%) diet, and received DHA (300
320. mg/kg) daily by gavage for 8 weeks. Values are mean ± S.E.M, n=12. Brains were
321. then obtained and their phosphatide levels determined as described in the text. Data
322. are presented as nmol/mg protein.
323. * p<.05 compared to control group
324. ** p<.01 compared to control group
325. *** p<.001 compared to control group
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Figure 1. The effects of a UMP-supplemented diet and/or daily administration of DHA
on acquisition of a four arm radial maze with two arms baited in gerbils. Values are
mean ± S.E.M, n=12. A. Reference memory errors (UMP p <.038, DHA p< .042, UMP x
DHA p< .001). B. Working memory errors (UMP p<.029, DHA p< .035, UMP x DHA
p<.001). C. Total errors (UMP p<.022, DHA p< .034, UMP x DHA p<.001).
Figure 1
Reference Memory Errors
--- Control
-e-0.5% UMP
--&-300mglkg DHA
--- 0.5% UMP + 300mg/kg DHA
120
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17
Trial
z
- ·------- ?
Sessions to Reach Criterion
18
0.5% UMP 300mg/kg DHA 0.5% UMP +
300mg/kg DHA
T-Maze Delay Memory Test
-I--
Control 0.5% UMP 300mg/kg DHA 0.5% UMP +
300mg/kg DHA
Figure 2. The effects of a UMP-supplemented diet and/or daily administration of DHA
on acquisition of a T-maze with one arm baited in gerbils. Values are mean + S.E.M,
n=12. A. Acquisition of the task was affected sessions to reach criterion (UMP p < .038,
DHA p < .024, UMP x DHA p < .017). B. Retention of the task was affected percent
correct in a 24 hour delay memory test (UMP p <.04, DHA p < .036, UMP x DHA
p<.021).
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Figure 3. The effects of a UMP-supplemented diet and/or daily administration of DHA
on acquisition of a Y-maze with a four day delay memory test. Values are mean ±
S.E.M, n=12. Retention of the task was affected percent correct (UMP p< .012, DHA p<
.009, UMP x DHA p <.001).
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Discussion
These data show that oral administration to gerbils of either dietary UMP (0.5%)
or gavaged DHA (300 mg/kg) causes gerbils to exhibit improved performance
on various tests of cognition, including a four arm radial maze, T-maze, and Y- maze
(figures 1, 2, 3). Co-administration of the UMP and DHA further enhance the
improvements in performance on these tasks. Our data also confirm that administration of
either UMP or DHA increases levels of brain phosphatides (PC and PE), concurrent with
improving the cognitive behaviors. Moreover, co-administration of UMP and DHA
increases levels of all of the other brain phospholipids measured (PC, PE, SM, PS, PI), and
total phospholipid levels (table 1). The increases in the brain phosphatide levels correlated
with improved performance on tests of cognition.
Previous studies have shown that consumption by rodents of a DHA-deficient diet
decreases performance on tests of cognition (39), although not all of the effects described
could be attributed to deficits in learning and memory. Rats fed a diet deficient in DHA
exhibited impaired spatial learning in the Barnes circular maze (39), and impaired spatial
learning and memory in the Morris water maze (11). Potential confounders were not
usually evaluated, as noted by the authors of these papers, and could not be excluded as
alternative explanations for many of the observations. Most behavioral tests measure a
combination of performance and behavioral characteristics (40); the results from
commonly used water and radial maze tests are highly dependent on locomotor ability and
visual recognition of cues. Rodents consuming a DHA restricted diet can develop poor
visual function (41), and also suffer from diminished synthesis of the saturated and
monounsaturated fatty acids (42) needed as energy sources (43), and from high levels of
inflammation (44). Therefore, rodents consuming diets deficient in choline or DHA may
experience adverse affects not related to learning and memory, which may influence their
performance on tests of cognition. In the present study, all gerbils consumed diets that did
not restrict their consumption of DHA, hence the likelihood that improvement in
performance was based on locomotor ability or visual acuity was reduced.
Although some previous studies have shown that administration of DHA or UMP given
alone can improve memory, this to our knowledge is the first study to demonstrate that co-
administration of UMP further enhances the effects of DHA. This probably reflects the
fact that, prior to the 2006 demonstration that the two compounds potentiate each others'
effects on phosphatide synthesis (7), there was no compelling reason to examine their
possible interaction in promoting cognition. DHA administration to rodents was previously
shown to improve performance on tests of cognition that measure spatial learning such as
the radial maze (3,4), Morris water maze (45), and brightness discrimination learning task
(46). Chronic administration of UMP (0.1%) improved the hippocampal-dependent
memory deficits associated with rearing rats in an impoverished environment (18). Results
from the present study show that DHA and UMP apparently act in synergy to produce
further improvements in learning acquisition and in retention of spatial memory.
In humans, administration of DHA can also improve performance on tests of cognition.
DHA supplemented formulas fed to term infants (47) and pre-term infants (48, 49) resulted
in improved performance in cognitive or behavioral tests, and on visual acuity (47). Infants
of women who have higher levels of DHA in their breast milk have higher scores on the
NBAS Range of State cluster score, suggesting that the DHA may maintain optimal arousal
in infants (50). DHA supplementation of infant formula improved visual and cognitive
maturation during infancy, and visual and cognitive outcomes at 1 year (51) and 4 years of
age (52). Results from the present study indicate that cognition in humans may be further
improved if DHA and UMP are administered in combination.
Changes in brain phosphatide levels following administration of DHA and UMP may
contribute to improved cognition in gerbils. Synthesis of the brainphosphatide
phosphatidylcholine, the most abundant constituent of cellular membranes (53), is
increased by consumption of the uridine source UMP (7). Plasma uridine crosses the
blood-brain barrier (BBB) (54), and increases brain uridine levels (14). This uridine is
converted, via UTP, to cytidine triphosphate (CTP), which combines with phosphocholine
(formed by the phosphorylation of choline) to yield cytidine-5' diphosphate choline (CDP-
choline), the immediate precursor of PC (55). The CDP-choline then combines with a
diacylglycerol (DAG), preferentially one containing a polyunsaturated fatty acid (PUFA)
moity such as DHA, to form PC (16). The UTP also acts as a ligand for P2Y receptors
(15).
DHA and UMP supplementation increased phospholipid content and synaptic protein
levels (7), and increased dendritic spine density in the gerbil hippocampus (13). In the
present study, we confirmed that total phospholipid levels in the brain are increased with
chronic consumption of DHA, and that co-administration with UMP further amplifies those
effects (table 1). We also observed that the level of phospholipids in gerbil brain following
8 weeks of DHA-UMP-choline administration is significantly higher than that described
previously following 4 weeks of treatment (7); implying that an asymptote has not yet been
reached. The likely mechanism by which DHA increases brain PC content is by increasing
the synthesis of the phosphatide, inasmuch as levels of PC's immediate precursor, CDP-
choline, are simultaneously depleted when DHA is administered (56).
Besides enhancing phosphatide synthesis, DHA but not analogs such as DPAn-6 (57)
produces additional effects on brain that could contribute to its behavioral effect. It lowers
levels of inflammation (58), has free radical scavenging capabilities (59), and affects brain
neurotransmitter levels (60), among other actions. The actions of UMP may also, as
mentioned above, be mediated in part through activation of P2Y receptors. Uridine and
UTP activate P2Y receptors in PC 12 cells, and can thereby increase turnover of
inositolphosphate (IP) (15), and calcium release from intracellular stores (61); these
cellular messengers also reportedly improve learning and memory in animals (62).
In summary, the present study demonstrates that increased consumption of either UMP
or DHA plus choline increases brain phospholipid content and improves the acquisition and
retention of spatial memory by gerbils. The largest increases in phospholipids and
enhancements in memory occur when choline, DHA, and UMP are administered in
combination.
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Chapter 2:
Chronic Administration of DHA and UMP Improves the Impaired Memory
of Impoverished Rats
Sarah Holguin, Yi Huang, Jenny Liu, Richard Wurtman
Abstract
Living in an enriched environment (EC) during development enhances
memory function in adulthood; living in an impoverished environment (IC)
impairs memory function. Compounds previously demonstrated to improve
memory among IC rats include CDP-choline and uridine mono phosphate (UMP).
Brain phosphatidylcholine (PC) synthesis utilizes both the pyrimidine formed
from CDP-choline or UMP, and the choline formed from CDP-choline. It also
uses the polyunsaturated fatty acid (PUFA) DHA, a precursor for the
diacylglycerol used in PC synthesis. DHA administration also improves
cognition in young and aged rodents and humans. We examined the effects of co-
administering DHA and UMP on hippocampal- and striatal- dependent forms of
memory among rats exposed to EC or IC for 1 month starting at weaning. In the
present study, we show that IC rats receiving either dietary UMP (0.5%) or
gavaged DHA (300 mg/kg) exhibit improved performance on the hidden version
of the Morris water maze (all p<0.05), a hippocampal-dependent task. Co-
administration of UMP and DHA further enhances the IC rats' performance of
this task (p<0.001). UMP plus DHA administration does not affect EC rats
performance on the hidden version of the Morris water maze (p>0.05), nor the
performance of IC or EC rats on the visible version of the Morris water maze (all
p>0.05), a striatal-dependent task. We have also confirmed that co-administration
of UMP and DHA to rats increases brain levels of the phosphatides PC, PE, SM,
PS, PI, and total phospholipid levels (all p<0.05), and that animals reared in the
enriched environment have brain PC, PS, and PI levels that are 57%, 25%, and
41% higher, respectively (all p<0.01) than those of animals reared in an IC
environment. Total phospholipid levels were also significantly higher in EC
control rats than in IC control rats by 25% (p<0.01). These results suggest that
giving DHA plus UMP can ameliorate memory defecits associated with rearing
under impoverished conditions, and that this effect may be mediated through
enhanced synthesis of brain membranes.
Introduction
Changes in an animal's environment, and the ways in which that animal
reacts to those changes, can have significant long-term effects on the brain and
behavior [1]. Laboratory rodents are normally reared under standard conditions
(SC), during which rats are housed individually, with few novel objects to interact
with. Recently, rodents have been reared under enriched (EC) or impoverished
conditions (IC) to determine differences in cognition acquired through increased
or decreased environmental stimuli. Rats reared under EC are typically housed in
larger cages, with more cage mates, and novel objects to interact with. Rodents
reared under IC are housed in smaller cages, isolated from other rodents, and in a
cage devoid of all unnecessary objects [2]. Rats exposed to EC conditions have
improved memory compared to rats reared under SC [3]; rats exposed to IC
conditions have impaired memory [4].
Enrichment enhances memory performance in various learning tasks.
Enriched mice performed better on a water maze test of spatial memory [5, 6],
and enriched rats performed better on a T-maze [7] EC enhanced spatial learning
in adult and aged rats [8], and improved learning in rats with traumatic brain
injury (TBI) [9]. The hippocampus, which is essential in learning and memory
[1], is the brain region most profoundly effected by exposure to an enriched or
impoverished environment [10].
Impoverishment impairs memory function in various learning tasks; some
compounds can protect rodents from memory impairments. IC rats demonstrated
deficits when tested on a T-maze [3], and Morris water maze [11]. Rats exposed
to IC have hippocampal-dependent memory deficits [4]. Compounds previously
demonstrated to improve the memory of IC rats include CDP-choline and uridine
mono-phosphate (UMP). Long-term dietary supplementation with either CDP-
choline, a source of choline and cytidine (in rats) or uridine (in humans),
prevented memory impairment in IC rats tested on a hippocampal- dependent
spatial task [12, 13].
PC synthesis requires the use of three circulating compounds; choline, a
pyrimidine such as uridine, and a polyunsaturated fatty acid (PUFA) such as
docosahexaenoic acid (DHA) [14]. Furthermore, consumption of DHA, one of
the precursors to PC, improves learning and memory when given during
development [15], or to aged rats [16]. Chronic administration of either UMP or
DHA increased brain phosphatide levels, the largest increase occurred when DHA
and UMP were administered in combination [14].
DHA, uridine, and choline administration increase phosphatide synthesis
because the enzymes involved are of low affinity and unsaturated by their
substrates. Choline is phosphorylated by choline kinase (CK) to form
phosphocholine, uridine is phosphorylated by uridine-cytidine kinase (CDK) to
form uridine triphosphate (UTP) [17], which is transformed to cytidine
triphosphate (CTP) by the enzyme CTP synthetase [18]. DHA is acylated by fatty
acyl-CoA synthetase [19]. Phosphocholine and CTP combine to form cytidine-
5'-diphosphocholine (CDP-choline), which combines with diacylglycerol (DAG)
to form phosphatidylcholine (PC) [20]. DAG containing polyunsaturated fatty
acids (PUFA) such as DHA is preferentially incorporated into PC [19, 21]. The
synthesis of phosphocholine by choline kinase (CK) is enhanced in animals [22]
or humans [23] given choline because CK is not saturated by its substrate, choline
at normal plasma and brain levels [18]. Uridine conversion to UTP and CTP is
enhanced in PC12 cells [24] and rodent brain [14] when uridine-cytidine kinase
(UCK) [25, 26, 27, 28, 29, 30] is saturated following pyrimidine administration
[17]. Also, the concentrations of plasma and brain CTP do not saturate CTP:
phosphocholine cytidylyltransferase (CT) [31], or its uptake into brain [32].
Giving animals DHA and choline plus uridine increases enzyme saturation by all
three of these precursors, and thus maximally potentiates synthesis of PC and
other phosphatides [14].
Increased brain phosphatide levels may enhance learning and memory
[33]. We thus examined the effect of DHA and UMP on hippocampal- and
striatal- dependent forms of memory among rats exposed to EC or IC for 1 month
starting at weaning, using the hidden and visible versions of the Morris water
maze. Subsequently, brain samples were analyzed for their phospholipid content
and a correlation determined between increased brain phosphatides and improved
performance on the water maze task.
Materials and Methods
Rats and Diet.
Male Sprague Dawley rats, 4 weeks of age, were purchased from Charles
River Laboratories, Wilmington, MA, and were housed in a climate-controlled
area kept on a 12:12 light cycle (lights on at 7:00 h). At this time, rats were
matched according to body wt and assigned to either the IC or EC group.
Subgroups of IC rats were given either control diet, 0.5% UMP supplemented
chow, 300 mg/kg DHA daily by gavage, or 0.5% UMP and 300 mg/kg DHA daily
by gavage. Subgroups of EC rats were also given either control diet, 0.5% UMP
supplemented chow, 300 mg/kg DHA daily by gavage, or 0.5% UMP and 300
mg/kg DHA daily by gavage. Rats were weighed weekly to ensure that treated
and untreated rats were eating equivalent amounts of food. Efforts were made to
minimize animal suffering, according to NIH guidelines. Protocols were
approved by the Committee on Animal Care [Massachusetts Institute of
Technology's Institutional Animal Care and Use Committee (IACUC).]
Environmental Conditions
Rats were housed in the same rack in plastic cages with wire lids. Bedding
and water were regularly changed, and rats had ad libitum access to food and
water. EC rats were housed in groups of 2, in cages containing plastic toys
(blocks, balls, PVC tubing, etc.). Toys were rotated between groups twice a
week; new toys were introduced weekly. EC rats were exposed to a "playroom"
measuring 5 ft x 5 ft every other day for 45 min. The "playroom" contained
several toys including plastic tubing, small balls, plastic boxes, wire brushes, and
paper towels to shred. The IC rats were housed individually, without toys, and
handled 3 times/week. IC rats were allowed to exercise 3 times/week for 15 min
in an empty room measuring 5 feet x 5 feet, with only the experimenter present.
Water Maze Apparatus
The water maze was a galvanized circular tank, 6 feet in diameter and 2
feet in height. The tank was filled with water maintained at RT to a depth of 1
foot, and located in a dimly lit room containing several extramaze cues. Four
starting positions were spaced around the perimeter of the tank to divide the pool
into 4 equal quadrants. For the visible platform version of the water maze, a white
flag was attached to the top of the submerged platform and protruded above the
water surface. We mounted a video camera directly above the maze; this camera
was linked to a computer with video tracking software to automatically record the
escape latency (time to reach the platform), distance traveled (length of swim path
taken to find the platform), and swim speed of all rats (HVS Image).
Behavioral Test
All behavioral training was carried out as described previously [12, 13]
between 1400 and 1800 h, each experiment was repeated at least 3 times and by at
least 2 different experimenters who were blind to the treatments. Briefly, rats
were given 4 trials/day for 4 days to locate the hidden platform (1 cm below the
water surface), which remained in the same position for all trials for individual
rats (within 1 of 4 quadrants). If a rat did not find the platform within 90 sec, it
was guided to the escape platform by the experimenter. After mounting the
platform, rats were allowed to remain on the platform for 20 sec. Following each
trial, rats were removed from the maze and placed in a holding cage for a 30 sec
intertrial interval. On the fifth day, rats were given a probe test; the platform was
removed and the swim path and time spent searching in the quadrant of the pool
that previously contained the platform were measured over 60 sec.
In the visible version of the Morris water maze, rats were given 4
trials/day for 4 days to locate the visible platform; the visible escape platform was
placed in a different quadrant on each of the 4 trials. If a rat did not escape within
90 sec, it was manually guided to the escape platform by the experimenter. After
mounting the platform, rats remained on the platform for 20 sec. Following each
trial, rats were removed from the maze and placed in a holding cage for a 30 sec
intertrial interval.
Rotarod apparatus and testing
The rotarod apparatus consisted of a 3.2-cm-diameter rod (RRAC-3002;
O'Hara & Company, Tokyo, Japan). The rotarod test was performed according to
the procedure described previously [34]. Rats were tested on the rotarod
following the completion of all water maze testing. During the training period,
rats were placed on the rod, and rotation started at 4 rpm and gradually
accelerated to 40 rpm at a rate 0.15 rpm/s. The latency to fall (retention time) was
measured with a cutoff time of 4 min. Rats were trained for 3 consecutive days,
receiving four trials per day with a 1 h intertrial interval.
Sample Collection
Rat brains were obtained immediately following the conclusion of each
behavioral test by C02 anesthesia followed by decapitation and immediate
dissection of the whole brain. All brain tissue was weighed and homogenized in
DI water such that each sample contained the same ratio of tissue to water; i.e.,
20mg tissue:lmL water. Samples were stored at -80 C for further analysis.
Total DNA Assay
To determine the total DNA in each sample, previously described
techniques [35] were used. The DNA in homogenized brain tissue was compared
to standards. Briefly, known standards were diluted 50 Cpg/mL in DNA buffer
(50mM KH2PO4, 2mM EDTA, 250mM NaC1, pH=7.4); 10 ptL of standards and
homogenized tissue were placed in well plates (Falcon MicroTest 96-well Assay
Plate, optilux Black). Hoechst solution was diluted to 1 pg/p.L in DNA buffer, and
200p.L was added to standard- and sample-containing wells. Following a thirty
minute incubation at RT and in the dark, the plate was read and analyzed on
Thermo Labsystem Fluoroskan Ascent using Ascent software, at excitation 355
nm./emission 460 nm.
Total Protein Assay
To determine the total protein in each sample, previously described
techniques [35] were used. Homogenized brain tissues were compared to known
BSA standards. Briefly, BSA standards and samples were added to well plates
(clear Falcon Pro-Bind 96 well assay plate); CuSO4 solution was diluted 1:49 in
bichinconinic acid and added to all standard- and sample-containing wells.
Following a thirty-minute incubation at RT, the plate was read and analyzed on a
Bio Rad microplate reader, model 550, using Microplate Manager software, at
550 nm.
Total Phospholipid Assay
Total phospholipid content was determined by comparing samples to
potassium phosphate standards. Phosphatides were extracted using previously
described methods [36]: 1 mL homogenates were mixed with 3 mL of chloroform
and methanol mixture (2:1 v/v) and vortexed for 30 seconds. After cooling on ice
for I hour, the mixture was added to 1 mL deionized water, and then added to 3
mL of chloroform and methanol (2:1 v/v). After remaining at -4C for 18-20
hours, the mixture was separated by centrifugation at 3500 rpm for fifteen
minutes at 4C; 100 gpL aliquots of the bottom phase was dried in a savant
lyopholizer and then digested in 70% perchloric acid for 1.5 hours at 150 C.
Phosphatides were measured as described previously [37]: 300 ýtL of 15%
ascorbic acid and 200 giL of 5% ammonium molybdate was added to samples and
standards. These remained at RT for thirty minutes, and were then read on a
Perkin-Elmer Lambda 3B UV/VIS spectrophotometer, at 810 nm. The
absorbency reading of each sample was compared to the absorbency reading of
the standards to determine the phospholipid content in samples. This value was
adjusted according to the total DNA and protein determined previously.
Phospholipid Separation
To determine the amount of individual phospholipids, previously
described methods [38] were used. Digested samples were separated using thin
layer chromatography (TLC); 30 jtL of each sample was spotted onto Alltech
silica gel G channeled plates, placed in running buffer (30 mL chloroform, 34 mL
ethanol, 30 mL triethylamine, and 8 mL water) for 1.5 hours, and visualized by
spraying plates with petroleum ether containing 1,6-diphenyl-1,3,5-hexatriene and
viewing under UV light. The bands corresponding to individual phospholipids
were scraped, reconstituted in methanol, and dried overnight in a savant
lyopholizer. Following this initial separation step, procedures were the same as
those described for the total phospholipid assay above.
Data analysis
For all tests comparing 2 groups, two-tailed t-tests were used. For
comparisons involving more than one factor, or comparing more than 2 groups,
factorial ANOVA was used.
Results
Body wt.
Body weight did not differ between UMP, DHA, and environmental
conditions (data not shown), indicating that rats were eating equivalent amounts
of diet regardless of dietary supplementation or environmental conditions.
Effects of UMP, DHA, and Environmental Conditions on Rats Performance on a
Hippocampal-dependent Water Maze Test
All groups were able to learn the hidden version of the Morris water maze
to some degree, showing a decrease in the number of errors recorded over time
(figure 1A, B) and indicated by a significant main effect of day (block of 4
training trials per day) (p<0.001). Values are mean ± S.E.M, n=12 for each
group. A main effect of environment (p<0.001) and an environment x diet
interaction were also observed (p<0.05). IC rats treated with either UMP, DHA,
or UMP and DHA had decreased escape latencies compared to the IC control rats,
the largest decrease was observed in IC rats co-administered UMP and DHA;
UMP [F(1,12) = 7.563, p<.042], DHA [F(1,12) = 13.253. p< .035], and UMP x
DHA [F(1,12) = 27.635, p< .001] (figure lA). EC rats treated with either UMP,
DHA, or UMP and DHA did not acquire the task at a faster rate than did IC
control rats (p>0.05) (figure 1B). These results indicate that long-term dietary
treatment with UMP or oral DHA improves the spatial memory deficits normally
associated with impoverished conditions; spatial memory is further improved
when UMP and DHA are co-administered.
The results of the 60 sec probe test indicated that rats spent more time in
the quadrant that originally contained the platform, suggesting that all
experimental groups used spatial cues to locate the hidden platform (figure
1C).The percentage of swim time in the 4 quadrants during the probe test was
affected by environment (p<0.042), quadrant (p<0.001), and diet x environment
interaction (p<0.05). IC rats treated with UMP, DHA, or UMP and DHA spent
more time in the correct quadrant than did the IC control rats, UMP [F(1,12) =
7.845, p<0.025], DHA [F(1,12) = 12.374, p< 0.021], UMP x DHA [F(1,12) =
22.428, p<0.001) (figure 1C). EC rats treated with UMP, DHA, or UMP and
DHA did not spend more time in the correct quadrant than EC control rats
(p>0.05).
Effects of UMP, DHA, and Environmental Conditions on Rats Performance on a
Striatal-dependent Water Maze Test
All groups were able to learn the visible version of the Morris water maze
to some degree, showing a decrease in the number of errors recorded over time
(figure 2A, B) and a main effect of day (block of 4 training trials per day)
(p<0.001). Values are mean ± S.E.M, n=12. No other significant effects were
determined, suggesting that environment, UMP, and DHA have no effect on
striatal-dependent learning and memory.
Effects of UMP and DHA Supplementation on Rats Performance on an
Accelerating Rotarod Test
All groups were able to learn the rotarod task, showing an increase in the
length of time they are able to remain on the accelerating rotarod (figure 3), and
indicated by a significant main effect of day (block of four training trials/day)
(p<.015). Values are mean ± S.E.M, n=12. No other significant effects were
determined (p's > .05), suggesting that environment, UMP, and DHA have no
effect on motor activity.
Effects of a UMP- supplemented Diet alone or in Combination with DHA
Administration on Brain Phosphatide Levels in EC and IC Rats
Chronic consumption of UMP (0.5%) increased IC rats' brain PC, PS, and
PI levels significantly, by 23%, 28%, 46%, and 27%, respectively (Table 1).
Administration of DHA (300 mg/kg) to IC rats consuming control diet increased
rats' brain PC, SM, PS, and PI levels significantly, by 26%, 49%, 71%, and 59%,
respectively. Among IC rats receiving both UMP and DHA, brain PC, PE, SM,
PS, and PI levels rose significantly by 60%, 97%, 86%, 138%, and 100%,
respectively. Total phospholipids levels were also significantly increased in IC
rats administered DHA by 19%, and in IC rats administered both UMP and DHA,
by 29% (table 1). Two-way ANOVA revealed a significant effect of dietary UMP
or oral DHA on IC rats' brain PC, PE, PS, and PI levels (all p< .05). Two-way
ANOVA also revealed a significant effect administering DHA (p<.05) or co-
administering dietary UMP and oral DHA on IC rats brain total phospholipids
levels (p< .001). Similar results were obtained when data were expressed per jtg
DNA (data not shown).
Administration of DHA (300 mg/kg) to EC rats consuming control diet
increased rats' brain SM, PS, and PI levels significantly, by 66%, 30%, and 19%,
respectively (table 1). Among EC rats receiving both UMP and DHA, brain PC,
PE, SM, PS, and PI levels rose significantly by 18%, 46%, 100%, 107%, and
55%, respectively. Total phospholipids levels were significantly in EC rats co-
administered UMP and DHA (p<0.05), but were not significantly increased in EC
rats administered either UMP or DHA, or the combination of UMP and DHA (all
p>0.05) (table 1). Two-way ANOVA revealed a significant effect of oral DHA on
EC rats' brain SM, PS, and PI levels (all p< .05). Two-way ANOVA also
revealed a significant effect of dietary UMP and oral DHA on EC rats' brain PC,
PE, PS, and PI levels (all p< .05). Similar results were obtained when data were
expressed per pg DNA (data not shown).
An enriched environment increased rats' brain PC, PS, and PI levels by
57%, 25%, and 41%, respectively. Total phospholipid levels were also
significantly increased in EC control rats compared to IC control rats by 25%.
Two-way ANOVA revealed a significant effect of enriched environment on EC
rats' brain PC, PS, and PI levels (all p< 0.01). Two-way ANOVA also revealed a
significant effect of enriched environment on EC control rats compared to IC
control rats (p<.01).
Table 1. Effects of giving UMP-supplemented diet
on phosphatide levels in whole brain samples.
(0.5%) and DHA (300 mg/kg)
Treatment Total PL PC PE SM PS PI
(nmol/mg
protein)
IC-Control 420 ± 9 168 ± 6 74 ± 7 49 ± 8 24 ± 4 22 ± 3
IC-0.5% UMP 442 ± 12 206 + 8 95 ± 9* 52 ± 6 35 ± 5*** 28 ± 5*
IC-300mg/kg DHA 501 ± 7* 211 ± 11* 78 ± 6 73 + 5*** 41 ± 5*** 35 ± 5***
IC-0.5% UMP + 543 ± 269 ± 146 91 57 ± 6*** 44 ±
300mg/kg DHA 15* 9*** 10*** 6*** 4***
EC-Control 524 ± 223 ± 88 ± 9 47 ± 5 30 ± 5a 31 ±
11a 8aaa 6aa
EC-0.5% UMP 529 ± 9 212 ± 12 98 ± 11 49 ± 7 31 ± 4 28 ± 4
EC-300mg/kg 539 + 14 227 ± 7 77 ± 5 78 ± 39 ± 6** 37 ± 7*
DHA 8***
EC-0.5% UMP + 542 ± 12* 263 + 129 ± 8 94 ± 5 62 + 4* 8 ± 9***
300mg/kg DHA 11***
IC and EC rats were administered a UMP-containing (0.5%) diet, and received
DHA (300 mg/kg) daily by gavage for 6 weeks. Values are mean ± S.E.M, n=12.
Brains were then obtained and their phosphatides levels determined as described
in the text. Data are presented as nmol/mg protein.
* p<.05 compared to control group
** p<.01 compared to control group
*** p<.001 compared to control group
a p<0.05 EC control compared to IC control
aa p<0.01 EC control compared to IC control
aaa p<0.001 EC control compared to IC control
Discussion
These data show that IC rats administered either dietary UMP (0.5%) or
oral DHA (300 mg/kg) have improved performance on the Morris water maze, a
hippocampal-dependent task. Co-administration of UMP and DHA further
enhances the IC rats' improved performance on this task. We have also
confirmed that co-administration of UMP and DHA increases the level of brain
PC, PE, SM, PS, PI, and total phospholipid levels in rats. The increase in the rats'
brain phosphatide levels occurs in correlation with their improved performance on
tests of cognition demonstrating enhanced learning acquisition and retention of
spatial memory.
There are many models of cognitive impairment; we chose to use
environmental impoverishment because rats reared under IC produces cognitive
deficits [3, 4] that can be prevented by long-term dietary supplementation with
either CDP-choline or UMP [12, 13]. The cellular mechanisms associated with
impaired cognition in IC rats are similar to the mechanisms following damage or
degeneration in the central nervous system [39]. Thus, compounds that are able
to improve the memory of IC rats may also benefit patients with neuronal damage
[40].
We propose that UMP and DHA protect against cognitive impairment in
IC rats by increasing the formation of membrane, and possibly slowing the
degradation of membrane in the case of EC rats; thereby promoting
neurotransmission. Rats reared under IC display reduced phosphatide levels in
the brain (table 1), and reduced glutamatergic hippocampal transmission [3].
UMP and DHA administration increase the synthesis of phosphatides in the brain
[14], and increase the density of dendrites in the hippocampus [41], which utilizes
more synaptic membrane. DHA administration reversed the decline in GluR2 and
NR2B glutamate receptor subunits, thereby improving glutamatergic transmission
in the hippocampus [42]. In support of this interpretation, we confirmed
Wurtman R. et al., 2006 findings that administration of UMP and DHA increases
brain phosphatide levels (Table 1) and demonstrated that IC reared rats treated
with UMP plus DHA protected rats from memory impairment (Figure 1).
UMP and DHA may protect the brains of IC reared animals by restoring
neuronal function to levels normally observed in EC brains. Rats exposed to IC
conditions have decreased brain weight and size following 300 days in IC [43];
DHA deficiency decreases brain weight and size, while DHA administration
increases brain weight and size [44]. IC reared rats have decreased neurogenesis
[45] and synaptogenesis [46]; DHA promotes neurite outgrowth in hippocampal
neurons [47] and uridine promotes neurite outgrowth in PC12 cells [24]. DHA
supplementation increased brain-derived neurotrophic factor (BDNF) levels in
rats [48]; consuming a diet deficient in DHA decreased brain BDNF levels [49].
BDNF expression induces neurogenesis in the dentate gyrus of the hippocampus
[50].
There are many similarities between the neural effects of EC and of DHA
or UMP plus DHA administration. EC rodents have improved spatial memory
[8]; while administration of DHA improves cognitive impairment in mouse
models of mild cognitive dysfunction, brain lesions, and AD [51]. EC rats have
increased cell survival in C57BL/6 learning impaired mice [52], while DHA
increases cell survival in retinal photoreceptors [53]. EC rodents have increased
(nerve growth factor) NGF expression [54]; likewise DHA administation
increases expression of NGF [55]. EC rodents have increased BDNF mRNA
expression [8]; BDNF modulates synapsin 1 levels during learning [56].
Administration of UMP plus DHA increases synapsin 1 levels in gerbil brain [14].
EC rodents have increased release of acetylcholine [57]; likewise DHA
supplementation increases the release of potassium-evoked acetylcholine [58];
UMP supplementation increases the release of acetylcholine [59].
In summary, the present study demonstrates that increased consumption of
either UMP or DHA plus choline increases brain phospholipid content and
prevents memory impairment in IC reared rats. The largest increase in
phospholipids and protection from memory impairments occurs when choline,
DHA, and UMP are administered in combination. EC is implicated as a possible
course of treatment to prevent memory impairment in several diseases, including
traumatic brain injury (TBI) [40, 60], prenatal hypoxia and alcohol [61], epilepsy
[62], stroke [63], Huntington's Disease [64, 65], and depression [66]. Co-
administration of DHA and UMP may aid in the treatment of these patients as
well.
Acknowledgements
We thank Lisa Teather a for advice and assistance in preparing this paper.
We also thank Rona Stephanopoulos and Paul Jaffe for their assistance with
behavior and biochemistry assays. This study was supported by NIH grant MH-
28783 and the Center for Brain Sciences and Metabolism Charitable Trust.
Figure 1
Morris Water Maze - Hidden
- IC-Control
.. IC-0.5% UMP
IC-300mg/kg DHA
10 - --
0
1 2 3 4
Blocks of 4 Trials
Morris Water Maze - Hidden
90
80
70
S60
" 50
40 .
30
20
10
0
-- EC-Control
EC-0.5% UMP
EC-300mg/kg DHA
EC-0.5% UMP + 300mg/kg
DHA
1 2 3
Blocks of 4 Trials
90 -
80
70
+iiiai:i~ii~-
60
" 50
-U 40
30
w
20
B.
Probe Trial
60
50
C 40
30
20
E
10
0
IC-Control IC-0.5% IC- IC-0.5% EC-Control EC-0.5% EC- EC-0.5%
UMP 300mg/kg UMP + UMP 300mg/kg UMP +
DHA 300mg/kg DHA 300mg/kg
DHA DHA
re
Figure 1. The effects of environment, UMP, and DHA administration on memory
for a hippocampal-dependent hidden platform water maze in rats reared under EC
or IC conditions for 1 month immediately postweaning. Values are means +
SEM, n=12. A. IC rats administered UMP, DHA, or UMP and DHA had
decreased escape latencies compared to the IC control rats (all p< 0.05). B. EC
rats administered UMP, DHA, or UMP and DHA did not have decreased escape
latencies compared to the EC control rats (all p>0.05) C. The 60 sec probe test
was affected by environment (p<0.042), quadrant (p<0.001), and diet x
environment interaction (p<0.05).
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Figure 2. The effects of environment, UMP, and DHA administration on memory
for a striatal-dependent visible platform water maze in rats reared under EC or IC
conditions for 1 month immediately postweaning. Values are means + SEM,
n= 12. A. IC rats administered UMP, DHA, or UMP and DHA did not have
decreased escape latencies compared to the IC control rats (all p> 0.05). B. EC
rats administered UMP, DHA, or UMP and DHA did not have decreased escape
latencies compared to the EC control rats (all p>0.05).
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Figure 3. The effects of a UMP-supplemented diet and/or daily administration of
DHA on IC and EC rats tested on an accelerating rotarod motor activity test.
Values are mean ± S.E.M, n=12. The time spent on the rotarod was not affected
(p's.> .05).
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Conclusion
As described in the two manuscripts, I have shown that increasing brain
phospholipid levels by administering the phosphatide precursors UMP plus DHA also
enhances certain cognitive behaviors:. Gerbils consuming UMP and/or DHA perform
better on the radial arm maze, T-maze, and Y-maze than control, untreated gerbils
(Manuscript 1). Moreover, giving UMP plus DHA also protects impoverished rats from
the cognitive decline associated with living in an impoverished environment (Manuscript
2). The increases in brain phospholipid levels, in both gerbils and rats, caused by
administering these compounds correlate with the improvements in behavior.
(Manuscript 1, 2).
Although I did not measure the numbers of hippocampal dendritic spines or the
levels of synaptic proteins in my test animals, abundant published evidence indicates that
treatment with UMP plus DHA increases both (1, 2). . Therefore, I suggest that by
increasing phospholipid levels in brain, UMP plus DHA may increase synaptic
membrane, and the size and number of functional synapses, thus enhancing synaptic
transmission and contributing to the enhanced cognition observed in these studies.
Alzheimer's brains are deficient in DHA (3), and in synapses. Hence
supplementation with DHA could conceivably delay the progression of this disease,
particularly if given along with a uridine source like UMP. This treatment may also prove
useful in treating other neurological disorders associated with the loss of synapses; e.g.
stroke, cerebral palsy, Parkinson's disease, brain injury.
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